🌏 东南亚合规中心
🇻🇳 Vietnam法规

越南透析治疗报销政策合规指南:腹膜透析纳入医保关键要求

来源:VSS · VnExpress Vietnam

作者:东南亚合规中心编辑团队

TL;DR · 核心要点

本文基于Vantive高管在越美东盟商界圆桌会上的发言,揭示越南终末期肾病(ESRD)治疗体系中腹膜透析(PD)报销覆盖不足的核心合规瓶颈。关键信息包括:1)现行医保未覆盖PD相关门诊耗材、患者教育及随访管理费用;2)HD中心占比超80%,而PD中心仅约60家,结构失衡;3)农村患者因地理障碍和报销缺位难以获得PD服务;4)泰国‘PD优先’政策成效显著,为越南提供可借鉴路径。对企业影响:医疗器械进口商、透析设备服务商及本地化合作伙伴需加速对接越南医保局(VSS)与卫生部(MOH),推动PD耗材目录准入与定价备案,否则将错失快速增长的居家透析市场。

✅ 合规行动清单 · Compliance Checklist

  • 立即向越南社会保险局(VSS)提交腹膜透析耗材医保目录准入申请,同步准备MOH注册文件
  • 与越南卫生部(MOH)认证的三级医院合作开展PD患者教育与远程随访试点,积累本地化临床证据
  • 聘请越南持证医药事务顾问,于2026年Q3前完成PD设备及配套耗材的VSS价格备案与报销编码申请
  • Submit PD consumables for inclusion in the Vietnam Social Security (VSS) Reimbursement List by Q3 2026, supported by MOH registration and clinical evidence
  • Partner with MOH-accredited tertiary hospitals to pilot PD patient education and remote monitoring programs — required for future VSS reimbursement justification
  • Engage licensed Vietnamese regulatory consultants to complete VSS pricing filing and reimbursement code application for APD devices and disposables before December 2026

English Summary

This article highlights critical gaps in Vietnam’s health insurance reimbursement framework for peritoneal dialysis (PD), based on Vantive’s regional executive testimony at the U.S.-ASEAN Business Council roundtable (Jan 8, 2026). Key compliance points: PD-related outpatient consumables, patient education, and follow-up care are not reimbursed under current Vietnam Social Security (VSS) regulations; HD dominates ~80% of dialysis services despite PD’s cost and quality advantages; geographic access barriers persist due to urban concentration of centers. Foreign medical device firms, dialysis service providers, and distributors must engage VSS and MOH to secure inclusion of PD supplies in the national reimbursement list. No formal deadline is stated, but alignment with Vietnam’s National Strategy on Chronic Disease Control (2025–2030) is urgent. Failure to act risks exclusion from a rapidly scaling home-dialysis market.

⚡ 这篇文章的要点太复杂?让 AI 帮你 30 秒解读

立即咨询 →

常见问题解答

越南医保是否报销腹膜透析(PD)治疗?+
目前不完全报销。越南社会保险局(VSS)仅覆盖部分住院PD治疗费用,但门诊PD耗材、患者教育、远程随访及家庭护理支持服务尚未纳入医保目录,企业须主动推动准入。
外国透析设备商如何进入越南PD市场?+
必须先完成MOH医疗器械注册(Class B/C),再向VSS申请报销编码;建议联合本地分销商与三甲医院开展真实世界研究(RWS),增强VSS审批说服力。
PD相比血透(HD)在越南有哪些政策优势?+
PD具备成本节约(泰国实证节省8.3%医保支出)、缓解城市医疗挤兑、提升农村可及性等战略价值,越南正参考泰国‘PD优先’政策调整方向,存在制度红利窗口期。
远程患者管理(RPM)系统在越南PD中是否合规?+
RPM本身无专项法规,但须符合MOH《远程医疗服务指南》及个人数据保护法(Decree 13/2023/ND-CP),所有数据存储与传输必须经本地服务器备案,并获患者书面授权。
企业应优先对接越南哪个部门推进PD报销?+
核心是越南社会保险局(VSS),负责报销目录与支付标准;同时需协同卫生部(MOH)获取临床指南背书,并与财政部(MOF)沟通预算分配机制,形成跨部门政策合力。

相关关键词

Vietnam dialysis reimbursementperitoneal dialysis VietnamVSS health insurance coveragemedical device registration Vietnamhome dialysis policy Vietnam
📄 官方原文参考(英文)点击展开
Vantive executive discusses reframing Vietnam's dialysis challenge - VnExpress International The most read Vietnamese newspaper Follow us on Edition: International | Vietnamese Home News Politics Education Environment Traffic Crime Brainteaser Business DataSpeaks Property Billionaires Markets Companies Economy Money Quiz Tech Tech news Enterprises Personalities Vietnam innovation Challenge hub Travel Places Food Guide Visa Puzzle Life Trend Arts Celebrities Vogue Love Wellness Sports Football Boxing Marathon Tennis Golf Other sports Trivia World Perspectives Readers' Views VnE-GO Premium Contact Us © Copyright 1997 VnExpress.net. All rights reserved. Go Business DataSpeaks Property Billionaires Companies Markets Economy Money Quiz Copy link Most Read 1. Gold prices decline 2. Southeast Asia's 2nd most powerful passport achieves highest ranking ever 3. Vingroup proposes $3.5B bridge and underwater tunnel across Ho Chi Minh City bay 4. 'My dad doesn't deserve to be happy': Alysa Liu 5. Gasoline prices plummet 6. Singapore Airlines, Scoot extend flight cancellations amid escalating Middle East conflict 7. 11 Vietnamese universities among Southeast Asia's best in first regional ranking 8. Bargaining for brilliance: Vietnamese Stanford alumnus sends hundreds of compatriot scholars to US 9. Filipino tourist nearly dies after uterus ruptures during Hanoi trip 10. Vietnam building 27 mega real estate projects worth over $115B: report Vantive executive discusses reframing Vietnam's dialysis challenge By Dan Minh &nbspMarch 11, 2026 | 05:00 pm PT Vietnam's healthcare system is facing increasing pressure in the treatment of end-stage renal disease (ESRD), with only an estimated 5-10% of roughly 800,000 patients able to access therapy amid persistent overcrowding at hemodialysis (HD) facilities, according to a Vantive executive. The issue was discussed at a recent scientific roundtable hosted by the U.S.-ASEAN Business Council on Jan. 8, 2026, in Hanoi, titled "Strategy for transforming end-stage chronic disease treatment in Vietnam – Promoting home-based peritoneal dialysis: ensuring balance, expanding access, and enhancing sustainability."In this context, Paul Uthaichalanond, General Manager of Vantive for Malaysia, Thailand, Vietnam and Myanmar, shared regional perspectives on improving access to kidney care, including the role of home-based peritoneal dialysis (PD), which has been implemented in countries such as Thailand. Paul Uthaichalanond, General Manager of Vantive Malaysia, Thailand, Vietnam, and Myanmar. Photo courtesy of Vantive From your regional observations, what are the most critical structural constraints in Vietnam's current ESRD care system?Currently, Vietnam's ESRD care system faces three key structural constraints.First, the system relies heavily on HD, which accounts for about 80% of dialysis services. In 2025, around 43,000 patients nationwide received renal replacement therapy, yet capacity was concentrated in approximately 430 HD centers, compared to about 60 PD centers and 31 kidney transplant centers. This imbalance places pressure on hospitals, healthcare personnel and infrastructure.Second, there are significant geographic access barriers. Although around 61% of the population lives outside major cities, most dialysis services are located in urban areas. This limits access for patients in rural and remote regions, potentially leading to delayed treatment and poorer outcomes.Third, the uptake of alternative therapies remains limited. The absence of reimbursement for certain outpatient medical consumables and incomplete health insurance coverage for consultations, patient education and outpatient care management reduce providers' ability to introduce and sustain PD programs. As PD requires ongoing education and regular follow-up to ensure safe home-based care, limited financial support can weaken monitoring systems. As a result, adoption of PD remains relatively low despite its availability.Drawing on Vantive's global and regional experience, particularly Thailand's long-standing "PD First" policy, why is home dialysis considered a strategic lever for reducing pressure on the healthcare system?Thailand provides a relevant reference point. After evaluating a "PD-first" policy in 2004, the country formally implemented the policy in 2008 in a healthcare context that shared similarities with Vietnam, particularly in expanding access for rural and remote populations.Driven by considerations such as cost efficiency, clinical outcomes and workforce capacity, the policy enabled Thailand to scale up renal replacement therapy, with nearly 70,000 patients treated, including about 34,000 on continuous ambulatory peritoneal dialysis (CAPD). Authorities estimated savings of approximately 8.3% in the national health insurance budget.In 2022, Thailand introduced a "free choice" policy to expand access to HD and reduce patients' out-of-pocket costs. However, this shift led to workforce constraints and challenges in maintaining HD quality, along with increased healthcare spending compared with the earlier "PD-first" period.Following an impact assessment by the Health Intervention and Technology Assessment Program (HITAP), the Thai government reinstated the "PD-first" policy in April 2025, reflecting a reassessment of its role in balancing access, quality and cost control.Please clarify the clinical outcomes and quality control mechanisms when patients use automated peritoneal dialysis (APD) supported by remote patient management (RPM).Home Dialysis allows patients to perform dialysis at home, reducing the need for frequent hospital visits and enabling them to better maintain daily routines, employment and family life.Published evidence, including studies such as Peritoneal Dialysis in the Modern Era, indicates that patients receiving PD often report higher levels of autonomy and lower anxiety compared to in-center HD, contributing to improved quality of life.Clinically, approximately 80% of ESRD patients are considered suitable candidates for PD. With appropriate management, PD can provide outcomes comparable to HD, while preserving residual renal function, reducing hospitalization rates and serving as a bridge to kidney transplantation.In pediatric cases, reduced hospital visits may help ease caregiver burden and lower risks associated with disrupted care. When combined with digital tools such as remote patient monitoring, APD enables healthcare providers to track adherence and key clinical parameters, identify early signs of complications and intervene in a timely manner.To scale up home-based PD over the next five years, which elements of Vietnam's national kidney care policy framework could be strengthened to support wider access and sustained patient adherence?Sustaining home dialysis requires several key elements.A comprehensive reimbursement framework that adequately covers peritoneal dialysis pathways is important to ensure patient access to advanced therapies and to support healthcare teams in delivering consistent care.Coordination across the healthcare ecosystem is also critical. Public-private partnerships among government agencies, healthcare providers and private-sector stakeholders can help develop a scalable, patient-centered system. This may include standardized training programs, shared protocols for patient education and follow-up, and digital monitoring tools to maintain treatment quality and adherence.Regional experience suggests that clear governance, defined clinical standards, workforce development and quality oversight are central to scaling home dialysis effectively. Private partners can contribute through capacity building, innovation and supply chain support, including reliable home delivery of home dialysis supplies to patients in remote areas and data-sharing mechanisms to reduce the risk of shortages or treatment interruptions.How does Vantive commit to working alongside Vietnam's healthcare system to help build a sustai